Pramlintide
Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin
AstraZeneca · Phase 2 · Completed · Enrollment 274
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.